• Molecular NameGlycodiazine
  • SynonymGlidiazine; Glymidine
  • Weight309.346
  • Drugbank_IDDB01382
  • ACS_NO339-44-6
  • Show 2D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)1.79
  • pkaN/A
  • LogD (pH=7, predicted)0.51
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-1.89
  • LogSw (predicted, AB/LogsW2.0)0.21
  • Sw (mg/ml) (predicted, ACD/Labs)0.62
  • No.of HBond Donors1
  • No.of HBond Acceptors7
  • No.of Rotatable Bonds7
  • TPSA98.79
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA sulfonamide antidiabetic drug, structurally related to the sulfonylureas.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein binding90.0
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half life3.8 h
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A